ZAI LAB LIMITED Guarantor Obligations, Maximum Exposure, Undiscounted
ZAI LAB LIMITED (ZLAB) had Guarantor Obligations, Maximum Exposure, Undiscounted of CNY 300.00 million as of 2024-02-06, per its 10-Q filed 2024-05-08.
Discontinued › Notes
us-gaap:GuaranteeObligationsMaximumExposure · last filed 2024-05-08
- 2024-02-06: Guarantor Obligations, Maximum Exposure, Undiscounted 300.00M CNY.
CNY
| Period end | Guarantor Obligations, Maximum Exposure, Undiscounted |
|---|---|
| 2024-02-06 | 300.00M CNY 10-Q · filed 2024-05-08 |
USD
| Period end | Guarantor Obligations, Maximum Exposure, Undiscounted |
|---|---|
| 2024-02-06 | $42.00M 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |